Delivery Order SPE2DB22D2005-SPE2DB25FJQS2
- Not listed
- The Defense Logistics Agency awarded a $1,724.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $9,451.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $27,596 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and is scheduled for completion by July 30, 2025. The vaccine product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $18,963.22 with completion scheduled for July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,892.26 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 31, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract utilizes AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $27,961.22 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes. The contract, which is non-set-aside and competitively awarded, has a firm fixed price structure with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a $4,557.96 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes in 0.5 ML units, with a ceiling value of $10,003.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQS2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $6,899.00, with completion due by August 1, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare systems. AmerisourceBergen Drug Corp's primary role as a federal supplier involves providing comprehensive pharmaceutical and medical supply solutions to military and veteran healthcare systems through competitively awarded contracts. The parent company's extensive portfolio with the Defense Logistics Agency encompasses a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for TYPHIM VI vaccine syringes supports the Defense Health Agency and other government healthcare customers' ongoing medical supply requirements through AmerisourceBergen's established prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/31/25 |